Sinequan: Advanced Relief for Depression and Anxiety Disorders
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.30 | $54.43 (0%) | 🛒 Add to cart |
| 360 | $0.27
Best per pill | $108.86 $97.77 (10%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.98 | $59.47 (0%) | 🛒 Add to cart |
| 60 | $1.50 | $118.94 $89.71 (25%) | 🛒 Add to cart |
| 90 | $1.34 | $178.41 $120.95 (32%) | 🛒 Add to cart |
| 120 | $1.27 | $237.87 $152.20 (36%) | 🛒 Add to cart |
| 180 | $1.19 | $356.81 $213.68 (40%) | 🛒 Add to cart |
| 270 | $1.14 | $535.22 $307.42 (43%) | 🛒 Add to cart |
| 360 | $1.12
Best per pill | $713.62 $402.17 (44%) | 🛒 Add to cart |
| Product dosage: 75mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.75 | $52.41 (0%) | 🛒 Add to cart |
| 60 | $1.38 | $104.83 $82.65 (21%) | 🛒 Add to cart |
| 90 | $1.27 | $157.24 $113.90 (28%) | 🛒 Add to cart |
| 180 | $1.15 | $314.48 $206.63 (34%) | 🛒 Add to cart |
| 270 | $1.11 | $471.72 $299.36 (37%) | 🛒 Add to cart |
| 360 | $1.09
Best per pill | $628.95 $391.08 (38%) | 🛒 Add to cart |
Synonyms | |||
Sinequan (doxepin hydrochloride) is a tricyclic antidepressant (TCA) with a well-established profile for managing major depressive disorder and anxiety-related conditions. As a potent agent with both antidepressant and anxiolytic properties, it works by increasing the levels of certain neurotransmitters in the brain, namely serotonin and norepinephrine, to help restore emotional balance and improve overall mental well-being. Its sedative effects also make it particularly useful for patients experiencing sleep disturbances associated with depression. Clinicians value Sinequan for its efficacy in treatment-resistant cases and its versatility across a spectrum of anxiety disorders.
Features
- Active ingredient: Doxepin hydrochloride
- Available in oral capsule formulations (10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg)
- Also available as an oral concentrate solution for precise dosing
- Class: Tricyclic antidepressant (TCA)
- Mechanism: Serotonin and norepinephrine reuptake inhibition
- Half-life: Approximately 15 hours, supporting once-daily dosing
- Bioavailability: High with oral administration
- Metabolism: Hepatic, via CYP450 enzymes
Benefits
- Effectively alleviates symptoms of major depressive disorder, promoting improved mood and motivation.
- Reduces anxiety and associated physical symptoms, helping patients regain daily functional capacity.
- Improves sleep quality by addressing insomnia often comorbid with depression, thanks to its sedative properties.
- Provides relief for certain chronic pain conditions, such as neuropathic pain, due to its neuromodulatory effects.
- Offers a therapeutic option for patients who have not responded adequately to first-line antidepressants like SSRIs.
- Long half-life allows for flexible, often once-daily dosing, enhancing adherence and convenience.
Common use
Sinequan is primarily indicated for the treatment of major depressive disorder (MDD) and anxiety disorders, including generalized anxiety disorder (GAD). It is also used off-label for conditions such as insomnia, neuropathic pain, migraine prophylaxis, and pruritus (itching) associated with certain dermatological conditions. Its efficacy in treatment-resistant depression makes it a valuable option when other antidepressants have proven insufficient.
Dosage and direction
Dosage must be individualized based on patient response and tolerance. For depression and anxiety in adults, the usual starting dose is 75 mg/day, given in divided doses or as a single daily dose at bedtime. This may be gradually increased to a maximum of 300 mg/day for hospitalized patients or 150 mg/day for outpatients, under close medical supervision. For milder cases or elderly patients, lower starting doses (e.g., 25–50 mg/day) are recommended. The oral concentrate should be diluted with water, milk, or juice prior to administration. Dosage adjustments should be made cautiously, and treatment should continue for several months after symptom resolution to prevent relapse.
Precautions
Patients should be monitored for worsening depression, suicidal ideation, or unusual changes in behavior, especially at the beginning of therapy or during dosage adjustments. Sinequan may impair mental or physical abilities required for tasks such as driving or operating machinery. Caution is advised in patients with a history of seizures, cardiovascular disease, urinary retention, angle-closure glaucoma, or hyperthyroidism. Alcohol should be avoided, as it can potentiate CNS depression. Use in elderly patients may require dose reduction due to increased sensitivity to side effects.
Contraindications
Sinequan is contraindicated in individuals with known hypersensitivity to doxepin or other tricyclic antidepressants. It must not be used concomitantly with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy, due to the risk of serotonin syndrome. Additional contraindications include recent myocardial infarction, untreated narrow-angle glaucoma, and severe urinary retention.
Possible side effect
Common side effects may include drowsiness, dizziness, dry mouth, blurred vision, constipation, and weight gain. Less frequently, patients may experience orthostatic hypotension, increased sweating, or sexual dysfunction. Serious side effects, though rare, can include seizures, cardiac arrhythmias, hepatitis, or blood dyscrasias. Any unusual or severe symptoms should be reported to a healthcare provider immediately.
Drug interaction
Sinequan has the potential for significant interactions. It may enhance the effects of CNS depressants, including alcohol, benzodiazepines, and opioids. Concomitant use with other serotonergic drugs (e.g., SSRIs, SNRIs, triptans) increases the risk of serotonin syndrome. Drugs that inhibit CYP2D6 or CYP1A2 enzymes may increase doxepin levels. Anticholinergic agents can compound side effects like dry mouth and constipation. Sinequan may also reduce the efficacy of antihypertensive drugs and potentiate the effects of sympathomimetics.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling up on doses is not recommended, as it may increase the risk of side effects.
Overdose
Overdose of Sinequan can be severe and potentially fatal. Symptoms may include severe drowsiness, confusion, agitation, hallucinations, tachycardia, hypotension, respiratory depression, seizures, and coma. Cardiac arrhythmias are a particular concern. Management involves supportive care, gastric lavage if presented early, and activated charcoal. ECG monitoring is essential, and treatment of arrhythmias or seizures may be necessary. Immediate medical attention is critical.
Storage
Store at room temperature (20–25°C or 68–77°F), in a tightly closed container, away from light, moisture, and heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. The oral concentrate should be stored in the original bottle and discarded appropriately after use.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
Clinical studies and patient reports generally reflect positive outcomes with Sinequan, particularly in cases of treatment-resistant depression and severe anxiety. Many users note significant improvement in sleep and overall mood stability. However, side effects such as drowsiness and dry mouth are commonly mentioned. Healthcare providers often emphasize the importance of gradual titration and ongoing monitoring to maximize benefits and minimize adverse effects.